MedCity News August 20, 2020
Dee Kolanek

Attaining reimbursement often has the greatest impact on patient access and can progress a new treatment toward widespread adoption.

What is the road to nationwide local Medicare coverage of a novel technology? It has to start with a medical milestone of course – FDA approval of an innovative treatment method. For certain, receiving this approval is a critical distinction and one that typically requires years dedicated to clinical research.

However, once a first-in-class treatment becomes available commercially what comes next for physicians and the patients they’re treating? Attaining reimbursement often has the greatest impact on patient access and can progress a new treatment toward widespread adoption.

While the benefits are far-reaching, the path from FDA approval to reimbursement can be...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: CMS, FDA, Govt Agencies, Insurance, Medical Devices, Medicare
Boston Scientific’s $3.7B Axonics buy tops list of medtech M&A in 2024
Neuronetics wins FDA clearance for device to treat adolescents with depression
J&J in talks to buy Shockwave Medical: WSJ
Roche develops continuous glucose monitor with predictive algorithms
MedCity Pivot: A Conversation About Wearable Robots with Scott Davis

Share This Article